Patent details

EP3737679 Title: NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS

Basic Information

Publication number:
EP3737679
PCT Application Number:
US2019013060
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP197034408
PCT Publication Number:
WO2019140095
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF SOLUBLE GUANYLATE CYCLASE STIMULATORS
French Title of Invention:
NOUVEAUX PROCÉDÉS ET INTERMÉDIAIRES POUR LA PRÉPARATION DE STIMULATEURS DE LA GUANYLATE CYCLASE SOLUBLE
German Title of Invention:
NEUARTIGES VERFAHREN UND ZWISCHENPRODUKTE ZUR HERSTELLUNG VON LÖSLICHEN GUANYLATCYCLASESTIMULATOREN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
05/10/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
02/11/2023
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
06/09/2023
Unitary Effect Registration Date:
02/11/2023
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
10/01/2019
Grant date:
06/09/2023
EP Publication Date:
18/11/2020
PCT Publication Date:
18/07/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/09/2023
EP B1 Publication Date:
06/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/01/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/08/2023
 
 

Name:
Cyclerion Therapeutics, Inc.
Address:
245 First Street Riverview II, 18th Floor, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
HASHASH, Ahmad
Address:
United States (US)

2

Name:
KISSEL, William
Address:
United States (US)

3

Name:
ZHOU, Fenger
Address:
United States (US)

4

Name:
NAKAI, Takashi
Address:
United States (US)

5

Name:
XUE, Song
Address:
United States (US)

6

Name:
KARNATI, Vishnu Vardhan Reddy
Address:
United States (US)

7

Name:
WANG, Yuguang
Address:
United States (US)

8

Name:
WALLACE, Debra Jane
Address:
United States (US)

9

Name:
SCHAIRER, Wayne C.
Address:
United States (US)

Priority

1

Priority Number:
201862615678 P
Priority Date:
10/01/2018
Priority Country:
United States (US)

2

Priority Number:
PCT/CN2018/076982
Priority Date:
22/02/2018
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
C07C 59/245; C07D 413/14; C07D 239/34; C07D 263/06; C07C 237/06;

Publication

European Patent Bulletin

1

Issue number:
202336
Publication date:
06/09/2023
Description:
Grant (B1)

2

Issue number:
202345
Publication date:
08/11/2023
Description:
Unitary Effect Request Receipt

3

Issue number:
202349
Publication date:
06/12/2023
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages